Literature DB >> 6885224

Predicting the outcome of endometrial hyperplasia by quantitative analysis of nuclear features using a linear discriminant function.

T J Colgan, H J Norris, W Foster, R J Kurman, C H Fox.   

Abstract

Nuclear parameters from 24 cases of atypical endometrial hyperplasia were determined by means of graphic tablet and microcomputer. Eight of the 24 hyperplasias progressed to carcinoma, but the remaining 16 did not progress during a mean follow-up period of 11.8 years. A linear discriminant function selected the mean and standard deviation of maximal nuclear diameter as useful predictors of clinical outcome. The linear discriminant function predicted the correct outcome in 83% of the cases. This study suggests that measurement of nuclear parameters in atypical endometrial hyperplasia may provide a more objective means of predicting the behavior of the various forms of hyperplasia.

Entities:  

Mesh:

Year:  1983        PMID: 6885224     DOI: 10.1097/00004347-198301040-00004

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  6 in total

1.  Nuclear size and shape of epithelial cells from the endometrium: lack of value as a criterion for differentiation between normal, hyperplastic, and malignant conditions.

Authors:  E Skaarland
Journal:  J Clin Pathol       Date:  1985-05       Impact factor: 3.411

2.  Diagnosis of premalignant endometrial disease.

Authors:  G L Mutter
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

3.  Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway.

Authors:  A Orbo; J P Baak; I Kleivan; S Lysne; P S Prytz; M A Broeckaert; A Slappendel; H J Tichelaar
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

4.  Evaluation of diagnostic efficiency of computerized image analysis based quantitative nuclear parameters in papillary and follicular thyroid tumors using paraffin-embedded tissue sections.

Authors:  N Gupta; C Sarkar; R Singh; A K Karak
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

5.  A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers.

Authors:  G L Mutter; M L Chaponot; J A Fletcher
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

6.  Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Diagn Pathol       Date:  2008-02-08       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.